In conclusion, our results integrate the data obtained in colorectal cancer and enlarge the knowledge about the interplay between EGFR and NEU3: the main effect of NEU3 is to facilitate of the interaction of EGFR monomers, leading to the activation of EGFR-downstream pathways in the absence of EGFR activating point mutations. Here, NEU3 is linked to colorectal cancer.